United States · FDA National Drug Code directory
Buprenorphine and Naloxone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-365_4db0df39-ce1f-bb08-e063-6294a90a3a4a
- Product NDC
- 50742-365
- Form
- FILM
- Composition / generic term
- buprenorphine and naloxone
- Labeler
- INGENUS PHARMACEUTICALS, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230829
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 12 mg/1
- NALOXONE HYDROCHLORIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (50742-365-30) / 1 FILM in 1 POUCH (50742-365-01) · 50742-365-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →